<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR520.html">Part 520
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 520.48  Altrenogest.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each milliliter (mL) of solution contains 2.2  milligrams (mg) altrenogest.</p><p class="depth1"><em>(b)</em> Sponsors. See sponsor listings in Sec. 510.600(c) of this  chapter:</p><p class="depth2"><em>(1)</em> No. 000061 for use as in paragraph (d) of this section.</p><p class="depth2"><em>(2)</em> No. 013744 for use as in paragraph (d)(1) of this section.</p><p class="depth1"><em>(c)</em> Tolerances. See Sec. 556.36 of this chapter.</p><p class="depth1"><em>(d)</em> Conditions of use--</p><p class="depth2"><em>(1)</em> Horses--</p><p class="depth3"><em>(i)</em> Amount. 1.0 mL per 110 pounds  body weight (0.044 mg/kg) daily for 15 consecutive days.</p><p class="depth3"><em>(ii)</em> Indications for use. For suppression of estrus in mares.</p><p class="depth3"><em>(iii)</em> Limitations. Do not use in horses intended for human  consumption. Federal law restricts this drug to use by or on the order  of a licensed veterinarian.</p><p class="depth2"><em>(2)</em> Swine--</p><p class="depth3"><em>(i)</em> Amount. Administer 6.8 mL (15 mg altrenogest) per  gilt once daily for 14 consecutive days by top-dressing on a portion of  each gilt's daily feed.</p><p class="depth3"><em>(ii)</em> Indications for use. For synchronization of estrus in sexually  mature gilts that have had at least one estrous cycle.</p><p class="depth3"><em>(iii)</em> Limitations. Do not use in gilts having a previous or current  history of uterine inflammation (i.e., acute, subacute or chronic  endometritis). Gilts must not be slaughtered for human consumption for  21 days after the last treatment.  [66 FR 47960, Sept. 17, 2001, as amended at 68 FR 62006, Oct. 31, 2003;  72 FR 9455, Feb. 21, 2008; 74 FR 61516, Nov. 25, 2009; 77 FR 32012, May  31, 2012]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
